Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Trichostatin A

HDAC inhibitor
 
BML-GR309-0001 1 mg 148.00 USD
 
BML-GR309-0005 5 mg 492.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-380-068

Trichostatin A (TSA) is a potent and reversible inhibitor of histone deacetylases. In HeLa cells, TSA blocked cell cycle progression at G1 and induced a 12-fold increase in intracellular levels of gelsolin. In cells latently infected with HIV-1, TSA induced the transcriptional activation of the HIV-1 promoter, which resulted in a marked increase in virus production. In NIH 3T3 cells, TSA induced reversion of oncogenic ras-transformed cells to a normal morphology. In Jurkat cells, TSA inhibited IL-2 gene expression (IC50=73nM) and displayed immunosuppressive activity in a mouse model.

Induces increased acetylation of GATA4, a cardiac-specific transcription factor and increases cardiac muscle cell differentiation. Trichostatin A is a useful tool for induction of hyperacetylation of cellular histones and for further elucidation of their role in gene expression. Induces cell growth arrest at both G1 and G2/M phases. may induce apoptosis in some cases. It can induce accelerated dedifferentiation of primordial germ cells into embryonic germ cells.

Product Specification

Alternative Name:[R-(E,E)]-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide
 
Formula:C17H22N2O3
 
MW:302.4
 
Source:Isolated from Streptomyces platensis.
 
CAS:58880-19-6
 
Purity:≥98% (HPLC)
 
Appearance:Off-white to beige solid.
 
MeltingPoint:150°C
 
Solubility:Soluble in DMSO, dimethyl formamide, acetonitrile, methanol or 100% ethanol
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Use/Stability:Store, as supplied, at -20°C for up to 1 year. Store solutions at -20°C for up to 3 months.
 
bml-gr309
Please mouse over
bml-gr309

Product Literature References

Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells: E. Di Zanni, et al.; Exp. Cell Res. 336, 43 (2015), Application(s): Cell Culture, Abstract;
Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells: K. Huber, et al.; J. Biol. Chem. 286, 22211 (2011), Abstract; Full Text
Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow: S. Snykers et al.; BMC Dev. Biol. 7, 24 (2007), Abstract;
Trichostatin A induces myocardial differentiation of monkey ES cells: M. Hosseinkhani et al.; Biochem. Biophys. Res. Commun. 356, 386 (2007), Abstract;
Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo: D.M. Vigushin; Clin. Cancer Res. 7, 971 (2001), Abstract;
Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells: P.A. Marks et al.; J. Natl. Cancer Inst. 92, 1210 (2000), Abstract;
Regulation of the human O(6)-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300: K.K. Bhakat & S. Mitra; J. Biol. Chem. 275, 34197 (2000), Abstract;
Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells: S.G. Gray et al.; Biochem. Biophys. Res. Commun. 245, 423 (1998), Abstract;
Retinoblastoma protein recruits histone deacetylase to repress transcription: A. Behm et al.; Nature 391, 597 (1998), Abstract;
A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells: S. Miucci et al.; PNAS 94, 11295 (1997), Abstract;
Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites: Y. Sowa et al.; Biochem. Biophys. Res. Commun. 241, 142 (1997), Abstract;
Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway: V. Medina et al.; Cancer Res. 57, 3697 (1997), Abstract;
A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p: J. Taunton et al; Science 272, 408 (1996), Abstract;
Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase: I. Takahashi et al.; J. Antibiot. (Tokyo) 49, 453 (1996), Abstract;
Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation: C. Van Lint et al.; EMBO J. 15, 1112 (1996), Abstract;
Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function: M. Yoshida et al.; Bioessays 17, 423 (1995), Abstract;
Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells: M. Futamura et al.; Oncogene 10, 1119 (1995), Abstract;
Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines: Y. Hoshikawa et al.; Exp. Cell Res., 214, 189 (1994), Abstract;
Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A: M. Yoshida et al.; J. Biol. Chem. 265, 17174 (1990), Abstract;
A new antifungal antibiotic, trichostatin: N. Tsuji et al.; J. Antibiot. (Tokyo) 29, 1 (1976), Abstract;

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

Brochures
Epigenetics
Epigenetics
Download as PDF

Catalogs
Diabetes Catalog
Diabetes Catalog
Download as PDF

Product Flyers
Cell Cycle - Mitosis, CDKS & Cell Cycle Signaling
Cell Cycle - Mitosis, CDKS & Cell Cycle Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,